| [1] |
Mallya S, Gangadhar V, Aldrin SE, et al. Insights into the molecular and genetic role of obesity in breast cancer pathogenesis [J]. Cancer biology & therapy, 2025, 26(1): 2501345
|
| [2] |
Pati S, Irfan W, Jameel A, et al. Obesity and cancer: A current overview of epidemiology, pathogenesis, outcomes, and management [J]. Cancers, 2023, 15(2): 485.
|
| [3] |
Murphy WJ, Longo DL. The surprisingly positive association between obesity and cancer immunotherapy efficacy [J]. JAMA, 2019, 321(13): 1247-1248.
|
| [4] |
Bader JE, Wolf MM, Lupica-Tondo GL, et al. Obesity induces PD-1 on macrophages to suppress anti-tumour immunity [J]. Nature, 2024, 630(8018): 968-975.
|
| [5] |
De Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth [J]. Cancer cell, 2023, 41(3): 374-403.
|
| [6] |
Liu C, Li X. Role of leptin and adiponectin in immune response and inflammation [J]. International immunopharmacology, 2025, 161: 115082.
|
| [7] |
Yang J, He J, Feng Y, et al. Obesity contributes to hepatocellular carcinoma development via immunosuppressive microenvironment remodeling [J]. Frontiers in immunology, 2023, 14: 1166440.
|
| [8] |
Nepal S, Kim MJ, Hong JT, et al. Autophagy induction by leptin contributes to suppression of apoptosis in cancer cells and xenograft model: involvement of p53/FoxO3A axis [J]. Oncotarget, 2015, 6(9): 7166-7181.
|
| [9] |
Ren G, Guo JH, Feng CL, et al. Berberine inhibits carcinogenesis through antagonizing the ATX-LPA-LPAR2-p38-leptin axis in a mouse hepatoma model [J]. Molecular therapy oncolytics, 2022, 26: 372-386.
|
| [10] |
Li F, Zhao S, Guo T, et al. The nutritional cytokine leptin promotes NSCLC by activating the PI3K/AKT and MAPK/ERK pathways in NSCLC cells in a paracrine manner [J]. BioMed research international, 2019, 2019: 2585743.
|
| [11] |
Lin MC, Wang FY, Kuo YH, et al. Cancer chemopreventive effects of lycopene: suppression of MMP-7 expression and cell invasion in human colon cancer cells [J]. Journal of agricultural and food chemistry, 2011, 59(20): 11304-11318.
|
| [12] |
Gorska E, Popko K, Stelmaszczyk-Emmel A, et al. Leptin receptors [J]. European journal of medical research, 2010, 15(Suppl 2): 50-54.
|
| [13] |
Wang H, Wang HS, Zhou BH, et al. Epithelial-mesenchymal transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancer [J]. PloS one, 2013, 8(2): e56664.
|
| [14] |
Nri-Ezedi CA, Ulasi T, Chukwuka J, et al. Serum total adiponectin in healthy pre-pubertal nigerian school children [J]. Nigerian journal of clinical practice, 2021, 24(6): 821-827.
|
| [15] |
Sun B, Karin M. Obesity, inflammation, and liver cancer [J]. Journal of hepatology, 2012, 56(3): 704-713.
|
| [16] |
Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review [J]. British journal of cancer, 2006, 94(9): 1221-1225.
|
| [17] |
Saxena NK, Fu PP, Nagalingam A, et al. Adiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma [J]. Gastroenterology, 2010, 139(5): 1762-1773.
|
| [18] |
Parida S, Siddharth S, Sharma D. Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease [J]. International journal of molecular sciences, 2019, 20(10): 2519.
|
| [19] |
Lohmann AE, Soldera SV, Pimentel I, et al. Association of obesity with breast cancer outcome in relation to cancer subtypes: a meta-analysis [J]. Journal of the National Cancer Institute, 2021, 113(11): 1465-1475.
|
| [20] |
Xu K, Yin N, Peng M, et al. Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity [J]. Science (New York, N.Y.), 2021, 371(6527): 405-410.
|
| [21] |
Turbitt WJ, Buchta Rosean C, Weber KS, et al. Obesity and CD8+ T cell metabolism: Implications for anti-tumor immunity and cancer immunotherapy outcomes [J]. Immunological reviews, 2020, 295(1): 203-219.
|
| [22] |
Ma S, Ming Y, Wu J, et al. Cellular metabolism regulates the differentiation and function of T-cell subsets [J]. Cellular & molecular immunology, 2024, 21(5): 419-435.
|
| [23] |
Cao J, Liao S, Zeng F, et al. Effects of altered glycolysis levels on CD8+ T cell activation and function [J]. Cell death & disease, 2023, 14(7): 407.
|
| [24] |
Zhang C, Yue C, Herrmann A, et al. STAT3 activation-induced fatty acid oxidation in CD8+ T effector cells is critical for obesity-promoted breast tumor growth [J]. Cell metabolism, 2020, 31(1): 148-161.
|
| [25] |
田亚红, 高向东, 姚文兵, 等. CD4+ T细胞在肿瘤免疫治疗中的作用与应用研究进展 [J]. 药学进展, 2024, 48(6): 463-470.
|
| [26] |
Shu P, Liang H, Zhang J, et al. Reactive oxygen species formation and its effect on CD4+ T cell-mediated inflammation [J]. Frontiers in immunology, 2023, 14: 1199233.
|
| [27] |
Brown ZJ, Fu Q, Ma C, et al. Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4+ T cell apoptosis promoting HCC development [J]. Cell death & disease, 2018, 9(6): 620.
|
| [28] |
Yamada K, Saito M, Ando M, et al. Reduced number and immune dysfunction of CD4+ T cells in obesity accelerate colorectal cancer progression [J]. Cells, 2022, 12(1): 86.
|
| [29] |
Alnafea HM, Korish AA. Activation of the peroxisome proliferator-activated receptors (PPAR-α/γ) and the fatty acid metabolizing enzyme protein CPT1A by camel milk treatment counteracts the high-fat diet-induced nonalcoholic fatty liver disease [J]. PPAR research, 2021, 2021: 5558731.
|
| [30] |
Huang X, Liu B, Shen S. Lipid metabolism in breast cancer: from basic research to clinical application [J]. Cancers, 2025, 17(4): 650.
|
| [31] |
Cheng X, Tan X, Wang W, et al. Long-chain acylcarnitines induce senescence of invariant natural killer T cells in hepatocellular carcinoma [J]. Cancer research, 2023, 83(4): 582-594.
|
| [32] |
Kosaraju R, Guesdon W, Crouch MJ, et al. B Cell activity is impaired in human and mouse obesity and is responsive to an essential fatty acid upon murine influenza infection [J]. Journal of immunology (Baltimore, Md. : 1950), 2017, 198(12): 4738-4752.
|
| [33] |
Nedal TMV, Moen SH, Roseth IA, et al. Diet-induced obesity reduces bone marrow T and B cells and promotes tumor progression in a transplantable Vk*MYC model of multiple myeloma [J]. Scientific reports, 2024, 14(1): 3643.
|
| [34] |
Kennedy DE, Knight KL. Inhibition of B lymphopoiesis by adipocytes and IL-1-producing myeloid-derived suppressor cells [J]. Journal of Immunology, 2015, 195(6): 2666-2674.
|
| [35] |
Frasca D, Romero M, Diaz A, et al. Obesity accelerates age defects in B cells, and weight loss improves B cell function [J]. Immunity & ageing , 2023, 20(1): 35.
|
| [36] |
Hu T, Zhai J, Yang Z, et al. Myeloid-derived suppressor cells in cancer: mechanistic insights and targeted therapeutic innovations [J]. MedComm, 2025, 6(6): e70231.
|
| [37] |
He S, Zheng L, Qi C. Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy [J]. Molecular cancer, 2025, 24(1): 5.
|
| [38] |
Yang Z, Huo Y, Zhou S, et al. Cancer cell-intrinsic XBP1 drives immunosuppressive reprogramming of intratumoral myeloid cells by promoting cholesterol production [J]. Cell metabolism, 2022, 34(12): 2018-2035.
|
| [39] |
Li C, Wang G, Sivasami P, et al. Interferon-α-producing plasmacytoid dendritic cells drive the loss of adipose tissue regulatory T cells during obesity [J]. Cell metabolism, 2021, 33(8): 1610-1623.
|
| [40] |
Prendeville H, Lynch L. Diet, lipids, and antitumor immunity [J]. Cellular & molecular immunology, 2022, 19(3): 432-444.
|
| [41] |
Kichenadasse G, Miners JO, Mangoni AA, et al. Association between body mass index and overall survival with immune checkpoint inhibitor therapy for advanced non-small cell lung cancer [J]. JAMA oncology, 2020, 6(4): 512-518.
|
| [42] |
Cortellini A, Bersanelli M, Buti S, et al. A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable [J]. Journal for immunotherapy of cancer, 2019, 7(1): 57.
|
| [43] |
Costante F, Airola C, Santopaolo F, et al. Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows [J]. World journal of gastrointestinal oncology, 2022, 14(9): 1622-1636.
|
| [44] |
Mastrolonardo EV, Llerena P, De Ravin E, et al. Improved survival with elevated BMI following immune checkpoint inhibition across various solid tumor cancer types [J]. Cancer, 2025, 131(6): e35799.
|
| [45] |
Ihara Y, Sawa K, Imai T, et al. Immunotherapy and overall survival among patients with advanced non-small cell lung cancer and obesity [J]. JAMA network open, 2024, 7(8): e2425363.
|
| [46] |
Sbierski-Kind J, Grenkowitz S, Schlickeiser S, et al. Effects of caloric restriction on the gut microbiome are linked with immune senescence [J]. Microbiome, 2022, 10(1): 57.
|
| [47] |
Hirayama A, Kami K, Sugimoto M, et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry [J]. Cancer research, 2009, 69(11): 4918-4925.
|
| [48] |
Urasaki Y, Heath L, Xu CW. Coupling of glucose deprivation with impaired histone H2B monoubiquitination in tumors [J]. PloS one, 2012, 7(5): e36775.
|
| [49] |
Schild T, Wallisch P, Zhao Y, et al. Metabolic engineering to facilitate anti-tumor immunity [J]. Cancer cell, 2025, 43(3): 552-562.e9.
|
| [50] |
Hardie D G. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function [J]. Genes & development, 2011, 25(18): 1895-1908.
|
| [51] |
Ma EH, Poffenberger MC, Wong AHT, et al. The role of AMPK in T cell metabolism and function [J]. Current opinion in immunology, 2017, 46: 45-52.
|
| [52] |
范晓轩, 王娜, 朱丽花, 等. 肥胖相关肿瘤研究进展 [J/OL]. 中华肥胖与代谢病电子杂志, 2023, 9(3): 173-178.
|
| [53] |
Boulenouar S, Michelet X, Duquette D, et al. Adipose type one innate lymphoid cells regulate macrophage homeostasis through targeted cytotoxicity [J]. Immunity, 2017, 46(2): 273-286.
|
| [54] |
Michailidou Z, Gomez-Salazar M, Alexaki VI. Innate immune cells in the adipose tissue in health and metabolic disease [J]. Journal of innate immunity, 2022, 14(1): 4-30.
|
| [55] |
李涛, 张侃, 杨文雨, 等. 免疫检查点抑制剂CTLA-4在实体肿瘤治疗中的临床应用 [J]. 协和医学杂志, 2023, 14(3): 652-659.
|